Skip to main content
Top
Published in: Rheumatology International 11/2008

01-09-2008 | Case Report

Severe hemorrhagic cystitis associated with prolonged oral cyclophosphamide therapy: case report and literature review

Authors: Ruo-Qi Hu, Hashim Mehter, Tibor Nadasdy, Anjali Satoskar, Dan N. Spetie, Brad H. Rovin, Lee Hebert

Published in: Rheumatology International | Issue 11/2008

Login to get access

Abstract

Severe hemorrhagic cystitis associated with oral cyclophosphamide (CYP) therapy has rarely been reported in the past 20 years, probably because this condition has largely disappeared because of the use of shorter courses of CYP, either oral or IV. Herein, we describe a patient who received 309 g of oral CYP over a 4-year period to treat Wegener’s granulomatosis (WG) that initially involved brain, lung, and kidney. She came under our care for the first time when she presented with a one-day history of oliguria and passing blood clots. Severe hemorrhagic cystitis was present. It eventually required cystectomy. Despite her massive CYP exposure her kidney biopsy showed acute crescentic glomerulonephritis. She survived her acute illness only to die 2 months later of acute leukemia. This patient is a reminder that severe hemorrhagic cystitis from oral CYP still exists, and that WG can be resistant to even toxic doses of oral CYP. Alternative therapies are discussed.
Literature
1.
go back to reference Watson NA, Notley RG (1973) Urological complications of cyclophosphamide. Br J Urol 45(6):606–609PubMedCrossRef Watson NA, Notley RG (1973) Urological complications of cyclophosphamide. Br J Urol 45(6):606–609PubMedCrossRef
2.
go back to reference Hutter AM Jr, Bauman AW, Frank IN (1969) Cyclophosphamide and severe hemorrhagic cystitis. N Y State J Med 69(2):305–309PubMed Hutter AM Jr, Bauman AW, Frank IN (1969) Cyclophosphamide and severe hemorrhagic cystitis. N Y State J Med 69(2):305–309PubMed
3.
go back to reference Bennett AH (1974) Cyclophosphamide and hemorrhagic cystitis. J Urol 111(5):603–606PubMed Bennett AH (1974) Cyclophosphamide and hemorrhagic cystitis. J Urol 111(5):603–606PubMed
4.
go back to reference Stillwell TJ, Benson RC Jr, DeRemee RA, McDonald TJ, Weiland LH (1988) Cyclophosphamide-induced bladder toxicity in Wegener’s granulomatosis. Arthritis Rheum 31(4):465–470PubMedCrossRef Stillwell TJ, Benson RC Jr, DeRemee RA, McDonald TJ, Weiland LH (1988) Cyclophosphamide-induced bladder toxicity in Wegener’s granulomatosis. Arthritis Rheum 31(4):465–470PubMedCrossRef
5.
go back to reference Langford CA (2003) Wegener’s granulomatosis: current and upcoming therapies. Arthritis Res Ther 5(4):180–191PubMedCrossRef Langford CA (2003) Wegener’s granulomatosis: current and upcoming therapies. Arthritis Res Ther 5(4):180–191PubMedCrossRef
6.
go back to reference Schmitt WH, Hagen EC, Neumann I, Nowack R, Flores-Suarez LF, van der Woude FJ (2004) Treatment of refractory Wegener’s granulomatosis with antithymocyte globulin (ATG): an open study in 15 patients. Kidney Int 65(4):1440–1448PubMedCrossRef Schmitt WH, Hagen EC, Neumann I, Nowack R, Flores-Suarez LF, van der Woude FJ (2004) Treatment of refractory Wegener’s granulomatosis with antithymocyte globulin (ATG): an open study in 15 patients. Kidney Int 65(4):1440–1448PubMedCrossRef
7.
go back to reference Christiansen DH, Andersen MK, Pedersen-Bjergaard J (2001) Mutations with loss of heterozygosity of p53 are common in therapy-related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor prognosis. J Clin Oncol 19(5):1405–1413PubMed Christiansen DH, Andersen MK, Pedersen-Bjergaard J (2001) Mutations with loss of heterozygosity of p53 are common in therapy-related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor prognosis. J Clin Oncol 19(5):1405–1413PubMed
8.
go back to reference de Groot K, Adu D, Savage CO (2001) The value of pulse cyclophosphamide in ANCA-associated vasculitis: meta-analysis and critical review. Nephrol Dial Transplant 16(10):2018–2027PubMedCrossRef de Groot K, Adu D, Savage CO (2001) The value of pulse cyclophosphamide in ANCA-associated vasculitis: meta-analysis and critical review. Nephrol Dial Transplant 16(10):2018–2027PubMedCrossRef
9.
go back to reference Nowack R, Gobel U, Klooker P, Hergesell O, Andrassy K, van der Woude FJ (1999) Mycophenolate mofetil for maintenance therapy of Wegener’s granulomatosis and microscopic polyangiitis: a pilot study in 11 patients with renal involvement. J Am Soc Nephrol 10(9):1965–1971PubMed Nowack R, Gobel U, Klooker P, Hergesell O, Andrassy K, van der Woude FJ (1999) Mycophenolate mofetil for maintenance therapy of Wegener’s granulomatosis and microscopic polyangiitis: a pilot study in 11 patients with renal involvement. J Am Soc Nephrol 10(9):1965–1971PubMed
10.
go back to reference Eriksson P (2005) Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab. J Intern Med 257(6):540–548PubMedCrossRef Eriksson P (2005) Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab. J Intern Med 257(6):540–548PubMedCrossRef
11.
go back to reference Specks U, Fervenza FC, McDonald TJ, Hogan MC (2001) Response of Wegener’s granulomatosis to anti-CD20 chimeric monoclonal antibody therapy. Arthritis Rheum 44(12):2836–2840PubMedCrossRef Specks U, Fervenza FC, McDonald TJ, Hogan MC (2001) Response of Wegener’s granulomatosis to anti-CD20 chimeric monoclonal antibody therapy. Arthritis Rheum 44(12):2836–2840PubMedCrossRef
12.
go back to reference Klemmer PJ, Chalermskulrat W, Reif MS, Hogan SL, Henke DC, Falk RJ (2003) Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis. Am J Kidney Dis 42(6):1149–1153PubMedCrossRef Klemmer PJ, Chalermskulrat W, Reif MS, Hogan SL, Henke DC, Falk RJ (2003) Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis. Am J Kidney Dis 42(6):1149–1153PubMedCrossRef
13.
go back to reference Garderet L, Bittencourt H, Sebe P et al (2000) Cystectomy for severe hemorrhagic cystitis in allogeneic stem cell transplant recipients. Transplantation 70(12):1807–1811PubMedCrossRef Garderet L, Bittencourt H, Sebe P et al (2000) Cystectomy for severe hemorrhagic cystitis in allogeneic stem cell transplant recipients. Transplantation 70(12):1807–1811PubMedCrossRef
14.
go back to reference Chong KT, Corman JM (2005) Hemorrhagic cystitis. In: Wessells H, McAninch JW (eds) Urological emergencies: a practical guide. Humana Press Inc, Totowa, pp 201–212 Chong KT, Corman JM (2005) Hemorrhagic cystitis. In: Wessells H, McAninch JW (eds) Urological emergencies: a practical guide. Humana Press Inc, Totowa, pp 201–212
15.
go back to reference Stillwell TJ, Benson RC Jr (1988) Cyclophosphamide-induced hemorrhagic cystitis. A review of 100 patients. Cancer 61(3):451–457PubMedCrossRef Stillwell TJ, Benson RC Jr (1988) Cyclophosphamide-induced hemorrhagic cystitis. A review of 100 patients. Cancer 61(3):451–457PubMedCrossRef
16.
go back to reference Hughes MJ, Davis FM, Mark SD, Spearing RL (2002) Hyperbaric oxygen for cyclophosphamide-induced cystitis. Br J Haematol 119(2):575PubMedCrossRef Hughes MJ, Davis FM, Mark SD, Spearing RL (2002) Hyperbaric oxygen for cyclophosphamide-induced cystitis. Br J Haematol 119(2):575PubMedCrossRef
17.
18.
go back to reference Berkson BM, Lome LG, Shapiro I (1973) Severe cystitis induced by cyclophosphamide. Role of surgical management. Jama 225(6):605–606PubMedCrossRef Berkson BM, Lome LG, Shapiro I (1973) Severe cystitis induced by cyclophosphamide. Role of surgical management. Jama 225(6):605–606PubMedCrossRef
19.
go back to reference Koc S, Hagglund H, Ireton RC, Perez-Simon JA, Collins SJ, Appelbaum FR (2000) Successful treatment of severe hemorrhagic cystitis with cystectomy following matched donor allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 26(8):899–901PubMedCrossRef Koc S, Hagglund H, Ireton RC, Perez-Simon JA, Collins SJ, Appelbaum FR (2000) Successful treatment of severe hemorrhagic cystitis with cystectomy following matched donor allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 26(8):899–901PubMedCrossRef
Metadata
Title
Severe hemorrhagic cystitis associated with prolonged oral cyclophosphamide therapy: case report and literature review
Authors
Ruo-Qi Hu
Hashim Mehter
Tibor Nadasdy
Anjali Satoskar
Dan N. Spetie
Brad H. Rovin
Lee Hebert
Publication date
01-09-2008
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 11/2008
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-008-0581-0

Other articles of this Issue 11/2008

Rheumatology International 11/2008 Go to the issue